Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_28847 | 131 | 2.73 | Mlig455_045073 | Neo: - Age: - |
Mlig455_045073 {REF} {Length: 588} {RNA1509_57120} {RNA1310_63606.1} {RNA815_49827} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.715 | 2.03 | 0.21301 | 0.85389 | |
RegionR2 | 1.988 | 2.03 | 0.10523 | 0.39981 | |
RegionR3 | 0.645 | 2.03 | 0.57128 | 1.00000 | |
RegionR4 | -1.445 | 2.03 | 0.99622 | 1.00000 | |
RegionR5 | 0.46 | 2.03 | 0.65324 | 1.00000 | |
RegionR6 | 0.143 | 2.03 | 0.80870 | 1.00000 | |
RegionR7 | 2.196 | 2.03 | 0.03273 | 0.34473 | |
RegionR8 | 1.728 | 2.03 | 0.19747 | 0.79401 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.323 | 2.03 | 0.99996 | 1.00000 | |
RegenerationR2 | 0.205 | 2.03 | 0.79669 | 0.98851 | |
RegenerationR3 | -0.476 | 2.03 | 0.63385 | 0.92200 | |
RegenerationR4 | 0.458 | 2.03 | 0.67350 | 0.94356 | |
RegenerationR5 | -0.291 | 2.03 | 0.75602 | 0.97366 | |
RegenerationR6 | -1.029 | 2.03 | 0.36850 | 0.71131 | |
RegenerationBL | -0.869 | 2.03 | 0.44178 | 0.80866 | |
RegenerationTP | -1.767 | 2.03 | 0.15640 | 0.58410 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_28847 | 131 | 2.73 | Mlig455_045073 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_045073 {REF} {Length: 588} {RNA1509_57120} {RNA1310_63606.1} {RNA815_49827} | |
2. | MligTC455_32445 | 285 | 5.93 | Mlig455_041727, Mlig455_042282 | Neo: - Age: - |
ANK2 | 3.361 | 0.877 | 0.704 | - | 0.807 | - | 0.973 | Mlig455_041727 {REF} {Length: 4931} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.7]; Ankyrin repeats (many copies) [PF13637.8, score=238.3]; Ankyrin repeat [PF00023.32, score=223.0]; Ankyrin repeats (many copies) [PF13857.8, score=214.9]; Ankyrin repeat [PF13606.8, score=201.4]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=211, Expect=1e-54]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=290, Expect=2e-80]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=210, Expect=2e-54]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=489, Expect=7e-151]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=745, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1, RNA1509_18945} {RNA1509_18945, RNA815_450.1} Mlig455_042282 {REF} {Length: 4940} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=273.8]; Ankyrin repeats (many copies) [PF13637.8, score=232.4]; Ankyrin repeat [PF00023.32, score=218.4]; Ankyrin repeats (many copies) [PF13857.8, score=210.6]; Ankyrin repeat [PF13606.8, score=197.5]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=214, Expect=2e-55]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=204, Expect=1e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=201, Expect=2e-51]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=205, Expect=6e-53]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=487, Expect=5e-150]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=736, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1} {RNA815_8298} |
3. | MligTC455_15051 | 112 | 2.33 | Mlig455_028585, Mlig455_056915 | Neo: - Age: - |
3.265 | 0.717 | - | - | 0.837 | 0.751 | 0.960 | Mlig455_028585 {REF} {Length: 982} {Smed: dd_Smed_v6_3795_0_2, dd_Smed_v6_3795_0_2, [RH, Score=86.7, Expect=1e-19]} {RNA1509_32017} {RNA1310_2395.2} {RNA815_496.1} Mlig455_056915 {REF} {Length: 1277} {Smed: dd_Smed_v6_3795_0_2, dd_Smed_v6_3795_0_2, [RH, Score=86.7, Expect=1e-19]} {RNA1509_32017} {RNA1310_2395.2} {RNA815_496.1} |
|
4. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
2.759 | 0.923 | - | - | 0.885 | - | 0.951 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
5. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 2.746 | 0.901 | - | - | 0.887 | - | 0.958 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
6. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 2.728 | 0.890 | - | - | 0.873 | - | 0.965 | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
7. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
2.719 | 0.881 | - | - | 0.886 | - | 0.952 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
8. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 2.711 | 0.958 | - | - | 0.791 | - | 0.962 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
9. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
2.707 | 0.856 | - | - | 0.882 | - | 0.969 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
10. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.698 | 0.897 | - | - | 0.836 | - | 0.965 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
11. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 2.693 | 0.875 | - | - | 0.863 | - | 0.955 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
12. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 2.687 | 0.969 | - | - | 0.763 | - | 0.955 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
13. | MligTC455_43741 | 196 | 4.08 | Mlig455_018088 | Neo: - Age: Down-Up-Down |
PTBP1 | 2.686 | 0.968 | - | - | 0.750 | - | 0.968 | Mlig455_018088 {REF} {Length: 2775} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=116.9]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=52.7]; Occluded RNA-recognition motif [PF16842.7, score=26.8]} {Human: ENSG00000011304, PTBP1, polypyrimidine tract binding protein 1, [Score=258, Expect=8e-80]; ENSG00000117569, PTBP2, polypyrimidine tract binding protein 2, [Score=258, Expect=1e-80]; ENSG00000119314, PTBP3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-76]} {Mouse: ENSMUSG00000028134, Ptbp2, polypyrimidine tract binding protein 2, [Score=258, Expect=7e-81]; ENSMUSG00000006498, Ptbp1, polypyrimidine tract binding protein 1, [Score=251, Expect=1e-78]; ENSMUSG00000028382, Ptbp3, polypyrimidine tract binding protein 3, [Score=248, Expect=1e-77]} {Dmel: FBgn0011224, heph, hephaestus, [Score=249, Expect=7e-78]} {Celegans: WBGene00004207, ptb-1, PTB (HnRNP) homolog; Putative RNA-binding protein PTB-1b, [Score=234, Expect=1e-72]} {Smed: dd_Smed_v6_1868_0_1, dd_Smed_v6_1868_0_1, [Score=214, Expect=4e-64]} {RNA1509_36451} {RNA1310_3345} {RNA815_23519} |
14. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 2.673 | 0.917 | - | - | 0.781 | - | 0.975 | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
15. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 2.672 | 0.906 | - | - | 0.811 | - | 0.955 | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
16. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 2.672 | 0.850 | - | - | 0.864 | - | 0.958 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
17. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
2.633 | 0.901 | - | - | 0.777 | - | 0.955 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
18. | MligTC455_53504 | 217 | 4.51 | Mlig455_037385 | Neo: - Age: - Region-enriched R2: 3.142/0.00738 |
CSMD1 | 2.632 | 0.872 | - | - | 0.808 | - | 0.952 | Mlig455_037385 {REF} {Length: 2214} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=198.7]} {Human: ENSG00000183117, CSMD1, CUB and Sushi multiple domains 1, [Score=149, Expect=8e-37]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=136, Expect=7e-33]; ENSMUSG00000060924, Csmd1, CUB and Sushi multiple domains 1, [Score=134, Expect=5e-32]; ENSMUSG00000022311, Csmd3, CUB and Sushi multiple domains 3, [Score=133, Expect=9e-32]} {Dmel: FBgn0032797, Hasp, Hig-anchoring scaffold protein, [RH, Score=218, Expect=3e-60]} {Celegans: WBGene00002976, lev-9, [RH, Score=244, Expect=4e-72]} {Smed: dd_Smed_v6_13071_0_1, dd_Smed_v6_13071_0_1, [RH, Score=296, Expect=1e-91]} {RNA1509_55985} {RNA1310_12867.1, RNA1509_55985} {RNA1509_55985, RNA815_9157} |
19. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.632 | 0.847 | - | - | - | 0.831 | 0.954 | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
20. | MligTC455_45496 | 144 | 2.99 | Mlig455_010048 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.720/0.00332 |
CAV2 | 2.631 | 0.819 | - | - | 0.842 | - | 0.970 | Mlig455_010048 {REF} {Length: 2607} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1, RNA1509_20287} {RNA1509_20287, RNA815_31873} |
21. | MligTC455_50729 | 93 | 1.94 | Mlig455_000196, Mlig455_067698 | Neo: - Age: logFC(26M/2M)=0.692 |
2.627 | 0.867 | - | - | 0.807 | - | 0.953 | Mlig455_000196 {REF} {Length: 3755} {RNA1310_22511} {RNA815_9029} Mlig455_067698 {REF} {Length: 3647} {RNA1310_22511} {RNA815_9029} |
|
22. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 2.625 | 0.840 | - | - | 0.806 | - | 0.979 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
23. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
2.612 | 0.850 | - | - | 0.792 | - | 0.970 | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
24. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 2.609 | 0.787 | - | - | 0.869 | - | 0.953 | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
25. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 2.605 | 0.896 | - | - | 0.735 | - | 0.974 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
26. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.602 | 0.931 | - | - | 0.709 | - | 0.962 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
27. | MligTC455_45712 | 91 | 1.89 | Mlig455_050761, Mlig455_050791 | Neo: - Age: - |
2.602 | 0.879 | 0.750 | - | - | - | 0.973 | Mlig455_050761 {REF} {Length: 2816} {RNA1509_10628} {RNA1310_39724.1} {RNA815_34935} Mlig455_050791 {REF} {Length: 2817} {RNA1509_10628} {RNA1310_39724.1} {RNA815_34935} |
|
28. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
2.598 | 0.817 | - | - | 0.827 | - | 0.954 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
29. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 2.597 | 0.815 | - | - | 0.827 | - | 0.955 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
30. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 2.58 | 0.830 | - | - | 0.773 | - | 0.977 | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
31. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
2.579 | 0.732 | - | - | 0.889 | - | 0.958 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
32. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
2.571 | 0.794 | - | - | 0.820 | - | 0.957 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
33. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 2.571 | 0.910 | - | - | 0.711 | - | 0.950 | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
34. | MligTC455_40118 | 72 | 1.5 | Mlig455_001236 | Neo: - Age: - |
KCNIP4 | 2.57 | 0.749 | - | - | 0.865 | - | 0.956 | Mlig455_001236 {REF} {Length: 1284} {Pfam: EF-hand domain pair [PF13499.8, score=42.4]; EF hand [PF00036.34, score=38.6]; EF-hand domain [PF13405.8, score=33.5]; EF hand [PF13202.8, score=31.2]; EF-hand domain pair [PF13833.8, score=28.7]} {Human: ENSG00000185774, KCNIP4, potassium voltage-gated channel interacting protein 4, [Score=122, Expect=2e-32]; ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=122, Expect=2e-32]; ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=119, Expect=1e-30]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=124, Expect=5e-33]; ENSMUSG00000029088, Kcnip4, Kv channel interacting protein 4, [Score=122, Expect=1e-32]} {Dmel: FBgn0013303, Nca, Neurocalcin, [Score=100, Expect=6e-25]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=103, Expect=5e-26]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=122, Expect=8e-33]} {RNA1310_43225} {RNA815_33406} |
35. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
2.565 | 0.801 | - | - | 0.811 | - | 0.953 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |
|
36. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
2.565 | 0.783 | - | - | 0.810 | - | 0.972 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
37. | MligTC455_50348 | 34 | 0.7 | Mlig455_012803 | Neo: - Age: - |
2.564 | 0.860 | - | - | 0.750 | - | 0.954 | Mlig455_012803 {REF} {Length: 488} {RNA1509_48155} {RNA1310_70969.2} {RNA815_39712} | |
38. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
2.557 | 0.723 | - | - | 0.875 | - | 0.959 | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
39. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.556 | 0.899 | - | - | 0.705 | - | 0.952 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
40. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.55 | 0.874 | - | - | 0.719 | - | 0.957 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
41. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
2.539 | - | - | - | 0.850 | 0.732 | 0.957 | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
42. | MligTC455_32633 | 189 | 3.93 | Mlig455_001739, Mlig455_001759, Mlig455_039278 | Neo: - Age: - Region-enriched R2: 4.593/0.00022 |
2.534 | 0.849 | - | - | 0.722 | - | 0.963 | Mlig455_001739 {REF} {Length: 1990} {Pfam: CD20-like family [PF04103.17, score=41.0]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [RH, Score=63.9, Expect=1e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [RH, Score=184, Expect=8e-59]} {RNA1310_42061} {RNA815_17286} Mlig455_001759 {REF} {Length: 3995} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=47.8, Expect=1e-06]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=150, Expect=6e-46]} {RNA1509_41966} {RNA1310_20375} {RNA815_17286} Mlig455_039278 {REF} {Length: 1821} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=122, Expect=1e-34]} {RNA1310_42061} {RNA815_17286} |
|
43. | MligTC455_37720 | 156 | 3.25 | Mlig455_027725, Mlig455_027921, Mlig455_027931 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.630/0.03113 |
TRPV6 | 2.531 | 0.737 | - | - | 0.844 | - | 0.950 | Mlig455_027725 {REF} {Length: 5690} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.6]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.7]; Polycystin cation channel [PF08016.14, score=27.5]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=4e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=1e-54]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=568, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=489, Expect=8e-156]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=492, Expect=6e-158]} {RNA1509_36869} {RNA1310_5278, RNA1509_36869} {RNA1509_36869, RNA815_5723} Mlig455_027921 {REF} {Length: 8298} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.2]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.8]; Polycystin cation channel [PF08016.14, score=27.1]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=5e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=9e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=566, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=1e-155]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=491, Expect=1e-157]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} Mlig455_027931 {REF} {Length: 6147} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=40.0]; Ankyrin repeat [PF13606.8, score=34.3]; Ankyrin repeats (many copies) [PF13857.8, score=31.5]; Ankyrin repeat [PF00023.32, score=30.2]; Polycystin cation channel [PF08016.14, score=27.8]; Ankyrin repeats (many copies) [PF13637.8, score=21.7]} {Human: ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=208, Expect=7e-56]; ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=1e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=3e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=567, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=5e-157]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=490, Expect=4e-159]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} |
44. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
2.529 | 0.743 | - | - | 0.831 | - | 0.955 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
45. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 2.528 | 0.792 | - | - | 0.783 | - | 0.953 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
46. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 2.522 | 0.742 | - | - | 0.822 | - | 0.958 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
47. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
2.515 | 0.752 | - | - | 0.804 | - | 0.959 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
48. | MligTC455_51559 | 43 | 0.89 | Mlig455_002923, Mlig455_002941 | Neo: - Age: - Region-enriched R2: 6.806/0.01463 |
2.514 | 0.794 | - | - | 0.769 | - | 0.951 | Mlig455_002923 {REF} {Length: 1008} {RNA1310_77227} {RNA815_43894} Mlig455_002941 {REF} {Length: 897} {RNA1310_88681} {RNA815_43894} |
|
49. | MligTC455_06865 | 658 | 13.71 | Mlig455_028132, Mlig455_028276 | Neo: - |
KCNC1 | 2.511 | - | - | - | 0.731 | 0.820 | 0.960 | Mlig455_028132 {REF} {Length: 2953} {Pfam: Ion transport protein [PF00520.33, score=118.6]; BTB/POZ domain [PF02214.24, score=80.7]; Ion channel [PF07885.18, score=39.5]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=281, Expect=8e-86]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=278, Expect=1e-83]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=281, Expect=6e-86]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=272, Expect=1e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=293, Expect=2e-91]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=296, Expect=3e-91]} {Smed: dd_Smed_v6_9740_0_1, dd_Smed_v6_9740_0_1, [Score=307, Expect=8e-96]} {RNA1509_33421, RNA1509_45695} {RNA1310_6306, RNA1509_33421, RNA1509_45695} {RNA1509_33421, RNA1509_45695, RNA815_9610} Mlig455_028276 {REF} {Length: 2587} {Pfam: BTB/POZ domain [PF02214.24, score=80.8]; Ion transport protein [PF00520.33, score=77.8]; Ion channel [PF07885.18, score=33.2]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=220, Expect=2e-63]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=220, Expect=2e-63]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=217, Expect=2e-62]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=220, Expect=2e-64]} {Smed: dd_Smed_v6_9740_0_1, dd_Smed_v6_9740_0_1, [Score=223, Expect=5e-65]} {RNA1509_33421} {RNA1310_6306} {RNA815_9610} |
50. | MligTC455_31626 | 38 | 0.79 | Mlig455_032857 | Neo: - Age: - |
SLC23A1 | 2.504 | - | - | - | 0.821 | 0.730 | 0.953 | Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063} |
51. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.488 | 0.821 | - | - | - | 0.708 | 0.959 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
52. | MligTC455_41055 | 112 | 2.34 | Mlig455_044574 | Neo: - Age: Up-Down-Down Region-specific R2: 4.659 Region-enriched R2: 6.247/0.00008 |
2.483 | - | - | - | 0.798 | 0.724 | 0.961 | Mlig455_044574 {REF} {Length: 1203} {Smed: dd_Smed_v6_9736_0_1, dd_Smed_v6_9736_0_1, [Score=86.7, Expect=1e-20]} {RNA1509_58567} {RNA1310_87689} {RNA815_53353} | |
53. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 2.478 | - | - | - | 0.781 | 0.727 | 0.970 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
54. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 2.473 | 0.798 | - | - | 0.719 | - | 0.956 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
55. | MligTC455_46880 | 44 | 0.91 | Mlig455_046271 | Neo: - Age: - |
IAH1 | 2.471 | 0.794 | - | - | 0.720 | - | 0.957 | Mlig455_046271 {REF} {Length: 1061} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=75.8]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.0]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=138, Expect=2e-39]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=121, Expect=4e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=111, Expect=8e-30]} {RNA1310_130726} |
56. | MligTC455_30366 | 614 | 12.78 | Mlig455_005372, Mlig455_005424, Mlig455_036242 | Neo: - Age: logFC(26M/2M)=-0.322 |
C20orf194 | 2.465 | - | - | - | 0.801 | 0.700 | 0.964 | Mlig455_005372 {REF} {Length: 2621} {Human: ENSG00000088854, C20orf194, chromosome 20 open reading frame 194, [Score=103, Expect=6e-22]} {Mouse: ENSMUSG00000027309, 4930402H24Rik, RIKEN cDNA 4930402H24 gene, [RH, Score=110, Expect=3e-24]} {Smed: dd_Smed_v6_10121_0_1, dd_Smed_v6_10121_0_1, [Score=89.7, Expect=3e-18]} {RNA1509_13613} {RNA1310_6491.1} {RNA815_2468} Mlig455_005424 {REF} {Length: 829} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_13613} {RNA1310_1263.1} {RNA815_2468} Mlig455_036242 {REF} {Length: 3746} {Human: ENSG00000088854, C20orf194, chromosome 20 open reading frame 194, [RH, Score=165, Expect=7e-41]} {Mouse: ENSMUSG00000027309, 4930402H24Rik, RIKEN cDNA 4930402H24 gene, [RH, Score=162, Expect=3e-40]} {Smed: dd_Smed_v6_10121_0_1, dd_Smed_v6_10121_0_1, [RH, Score=178, Expect=3e-45]} {RNA1509_13613} {RNA1310_6491.1, RNA1509_13613} {RNA1509_13613, RNA815_2468} |
57. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 2.453 | 0.733 | - | - | 0.763 | - | 0.957 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
58. | MligTC455_40654 | 676 | 14.08 | Mlig455_056785 | Neo: - Age: logFC(26M/2M)=-0.402 |
CCDC63 | 2.45 | 0.738 | - | - | 0.761 | - | 0.951 | Mlig455_056785 {REF} {Length: 2093} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=20.5]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [RH, Score=190, Expect=9e-53]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [RH, Score=179, Expect=7e-49]} {Dmel: FBgn0038452, CG14905, [RH, Score=168, Expect=6e-46]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [RH, Score=442, Expect=7e-150]} {RNA1509_17628} {RNA1310_12386, RNA1509_17628} {RNA1509_17628, RNA815_7054} |
59. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 2.434 | 0.724 | - | - | 0.747 | - | 0.963 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
60. | MligTC455_34925 | 183 | 3.82 | Mlig455_012715 | Neo: - Age: - |
CDKL1 | 2.422 | - | - | - | 0.756 | 0.710 | 0.956 | Mlig455_012715 {REF} {Length: 2370} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=250.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=120.6]; RIO1 family [PF01163.24, score=23.0]; ABC1 atypical kinase-like domain [PF03109.18, score=20.8]; Haspin like kinase domain [PF12330.10, score=20.4]; Kinase-like [PF14531.8, score=19.4]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=437, Expect=3e-153]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=424, Expect=2e-147]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=437, Expect=2e-153]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=432, Expect=2e-151]} {Dmel: FBgn0031730, CG7236, [RH, Score=384, Expect=3e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=388, Expect=3e-132]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=472, Expect=5e-167]} {RNA1509_44617} {RNA1310_15038, RNA1509_44617} {RNA1509_44617, RNA815_6379} |
61. | MligTC455_53842 | 1222 | 25.46 | Mlig455_023890 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.345 Region-enriched R2: 1.546/0.01667 |
2.42 | 0.706 | - | - | 0.754 | - | 0.960 | Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1} | |
62. | MligTC455_23599 | 300 | 6.25 | Mlig455_025579 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.645/0.00082 |
FBN2 | 2.404 | - | 0.725 | - | 0.722 | - | 0.957 | Mlig455_025579 {REF} {Length: 10696} {Pfam: Calcium-binding EGF domain [PF07645.17, score=312.2]; Complement Clr-like EGF-like [PF12662.9, score=241.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=125.1]; EGF domain [PF12947.9, score=95.9]; EGF-like domain [PF00008.29, score=59.7]; Human growth factor-like EGF [PF12661.9, score=47.9]; Thrombospondin type 1 domain [PF00090.21, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=21.3]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=250, Expect=2e-65]; ENSG00000166147, FBN1, fibrillin 1, [Score=248, Expect=1e-64]; ENSG00000142449, FBN3, fibrillin 3, [Score=243, Expect=3e-63]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=253, Expect=1e-66]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=251, Expect=5e-66]} {Dmel: FBgn0035798, frac, faulty attraction, [RH, Score=238, Expect=3e-62]} {Celegans: WBGene00001403, fbl-1, Fibulin-1, [Score=192, Expect=3e-50]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=294, Expect=3e-79]} {RNA1509_13106} {RNA1310_487} {RNA815_5734} |
63. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
2.397 | 0.703 | - | - | 0.729 | - | 0.965 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
64. | MligTC455_24302 | 149 | 3.11 | Mlig455_035632 | Neo: - Age: Up-Down-Up |
KCNQ5 | 2.389 | 0.702 | - | - | 0.723 | - | 0.964 | Mlig455_035632 {REF} {Length: 2263} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=124.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=122, Expect=1e-28]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [Score=121, Expect=2e-28]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=121, Expect=1e-28]; ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [Score=119, Expect=4e-28]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=175, Expect=1e-46]} {Celegans: WBGene00002235, kqt-3, KQT-3 potassium channel; Potassium channel, KvQLT family, [Score=110, Expect=1e-25]} {Smed: dd_Smed_v6_17359_0_2, dd_Smed_v6_17359_0_2, [Score=186, Expect=2e-52]} {RNA1509_34272} {RNA1310_3730.1} {RNA815_2787} |
65. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 1.92 | 0.957 | - | - | - | - | 0.963 | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
66. | MligTC455_15492 | 69 | 1.44 | Mlig455_022488 | Neo: - Age: Down-Up-Up |
1.913 | 0.968 | - | - | - | - | 0.945 | Mlig455_022488 {REF} {Length: 1351} {RNA1310_26051} {RNA815_10966} | |
67. | MligTC455_50288 | 118 | 2.47 | Mlig455_059182 | Neo: - Age: Up-Down-Down |
1.908 | 0.944 | - | - | - | - | 0.964 | Mlig455_059182 {REF} {Length: 3438} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=42.6]; Lectin C-type domain [PF00059.23, score=23.6]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [RH, Score=189, Expect=3e-53]} {RNA1509_45950, RNA1509_54781} {RNA1310_10757.1, RNA1509_45950, RNA1509_54781} {RNA1509_45950, RNA1509_54781, RNA815_5369} | |
68. | MligTC455_45735 | 175 | 3.64 | Mlig455_013937, Mlig455_039355 | Neo: - Age: Up-Down-Down |
1.897 | 0.935 | - | - | - | - | 0.962 | Mlig455_013937 {REF} {Length: 1369} {RNA1310_48389} {RNA815_22666} Mlig455_039355 {REF} {Length: 1299} {RNA1310_48389} {RNA815_22666} |
|
69. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 1.889 | 0.916 | - | - | - | - | 0.973 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
70. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 1.875 | 0.901 | - | - | - | - | 0.974 | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
71. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 1.867 | 0.909 | - | - | - | - | 0.958 | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
72. | MligTC455_35259 | 2265 | 47.19 | Mlig455_040978 | Neo: - Age: Up-Down-Down Region-specific R2: 2.606 Region-enriched R2: 1.588/0.00387 |
ADGRL2 | 1.862 | - | - | - | 0.895 | - | 0.967 | Mlig455_040978 {REF} {Length: 10808} {TRANSSPLICED} {Pfam: PDZ domain [PF00595.26, score=86.9]; 7 transmembrane receptor (Secretin family) [PF00002.26, score=76.2]; PDZ domain [PF17820.3, score=67.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=52.3]; PDZ domain [PF13180.8, score=36.4]; ZU5 domain [PF00791.22, score=30.8]; Guanylate kinase [PF00625.23, score=22.4]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=174, Expect=1e-42]} {Mouse: ENSMUSG00000034917, Tjp3, tight junction protein 3, [RH, Score=172, Expect=9e-43]} {Dmel: FBgn0262614, pyd, polychaetoid, [RH, Score=232, Expect=8e-61]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=174, Expect=4e-43]} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [RH, Score=833, Expect=0.0]} {RNA1509_17602, RNA1509_52679, RNA1509_58629} {RNA1310_236.2, RNA1509_17602, RNA1509_58629} {RNA1509_17602, RNA1509_58629, RNA815_77.1} |
73. | MligTC455_35783 | 47 | 0.99 | Mlig455_020624 | Neo: - Age: - |
1.861 | 0.906 | - | - | - | - | 0.955 | Mlig455_020624 {REF} {Length: 2007} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=58.9]} {Smed: dd_Smed_v6_14040_0_1, dd_Smed_v6_14040_0_1, [Score=64.3, Expect=2e-11]} {RNA1310_46235} {RNA815_34663} | |
74. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
1.86 | - | - | - | 0.882 | - | 0.978 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
75. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.858 | 0.896 | - | - | - | - | 0.962 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
76. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 1.858 | 0.897 | - | - | - | - | 0.961 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
77. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 1.855 | - | - | - | 0.893 | - | 0.962 | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
78. | MligTC455_16874 | 38 | 0.8 | Mlig455_028170 | Neo: - Age: - |
KCNK18 | 1.854 | 0.903 | - | - | - | - | 0.951 | Mlig455_028170 {REF} {Length: 2452} {Pfam: Ion channel [PF07885.18, score=103.1]; Protein of unknown function (DUF3112) [PF11309.10, score=20.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=96.7, Expect=1e-21]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=101, Expect=2e-23]} {Dmel: FBgn0033257, sand, sandman, [Score=129, Expect=2e-33]} {Celegans: WBGene00006680, twk-28, TWiK family of potassium channels, [Score=144, Expect=3e-38]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=270, Expect=2e-87]} {RNA1509_39975} {RNA1310_18301.1} {RNA815_12440} |
79. | MligTC455_52586 | 230 | 4.78 | Mlig455_069158 | Neo: - Age: - |
1.851 | - | - | - | 0.887 | - | 0.964 | Mlig455_069158 {REF} {Length: 3154} {RNA1509_45748, RNA1509_55217} {RNA1310_4688.1, RNA1509_45748} {RNA1509_45748, RNA815_38425} | |
80. | MligTC455_50661 | 79 | 1.64 | Mlig455_059106 | Neo: - Age: - |
1.848 | - | - | - | 0.865 | - | 0.983 | Mlig455_059106 {REF} {Length: 711} {NoTransDecoderORF} {RNA1310_39553.1} {RNA815_32589} | |
81. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
1.847 | - | - | - | 0.889 | - | 0.958 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
82. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 1.838 | - | - | - | - | 0.885 | 0.953 | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
83. | MligTC455_50660 | 81 | 1.7 | Mlig455_019591 | Neo: - Age: - |
SLC9B2 | 1.835 | - | - | - | 0.868 | - | 0.967 | Mlig455_019591 {REF} {Length: 2686} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=30.0]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=124, Expect=1e-31]} {Mouse: ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=116, Expect=1e-28]; ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=112, Expect=2e-27]} {Dmel: FBgn0263390, Nha2, Na[+]/H[+] hydrogen antiporter 2, [Score=113, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=70.9, Expect=2e-13]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=148, Expect=1e-43]} {RNA1509_34461} {RNA1310_39553.1} {RNA815_32589} |
84. | MligTC455_16872 | 306 | 6.37 | Mlig455_006228 | Neo: - Age: - Region-specific R2: 5.842 Region-enriched R2: 4.577/0.00000 |
1.833 | - | - | - | 0.870 | - | 0.963 | Mlig455_006228 {REF} {Length: 952} {RNA1310_48111} {RNA815_24753} | |
85. | MligTC455_54199 | 49 | 1.01 | Mlig455_034715, Mlig455_067590 | Neo: - Age: - Region-enriched R4: 5.064/0.03900 Regeneration-downregulated R4: -6.361 Regeneration-depleted R4: -6.361 |
1.832 | 0.866 | - | - | - | - | 0.966 | Mlig455_034715 {REF} {Length: 5399} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.4]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [Score=94.4, Expect=2e-21]} {RNA1310_64595} {RNA815_44335} Mlig455_067590 {REF} {Length: 3463} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=27.2]} {Smed: dd_Smed_v6_20712_0_1, dd_Smed_v6_20712_0_1, [Score=74.3, Expect=5e-15]} {RNA1310_64595} {RNA815_44335} |
|
86. | MligTC455_16962 | 22 | 0.45 | Mlig455_013331 | Neo: - Age: - |
PXDN | 1.827 | - | - | - | 0.877 | - | 0.950 | Mlig455_013331 {REF} {Length: 2939} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=51.7]; Immunoglobulin domain [PF13927.8, score=47.8]; Immunoglobulin domain [PF00047.27, score=41.8]; Immunoglobulin domain [PF13895.8, score=34.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=22.3]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=53.9, Expect=4e-07]; ENSG00000174498, IGDCC3, immunoglobulin superfamily DCC subclass member 3, [Score=53.1, Expect=9e-07]; ENSG00000113805, CNTN3, contactin 3, [Score=52.0, Expect=2e-06]; ENSG00000155657, TTN, titin, [Score=51.6, Expect=3e-06]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=54.3, Expect=3e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=52.8, Expect=8e-07]; ENSMUSG00000032394, Igdcc3, immunoglobulin superfamily, DCC subclass, member 3, [Score=52.8, Expect=8e-07]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=9e-07]} {Dmel: FBgn0003984, vn, vein, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00006776, unc-40, Unc-40 protein, [Score=53.9, Expect=2e-07]} {Smed: dd_Smed_v6_15790_0_1, dd_Smed_v6_15790_0_1, [RH, Score=70.5, Expect=3e-13]} {RNA1310_57623} {RNA815_38366} |
87. | MligTC455_40878 | 355 | 7.39 | Mlig455_014130 | Neo: - Age: - |
1.826 | - | - | - | 0.847 | - | 0.979 | Mlig455_014130 {REF} {Length: 1465} {RNA1509_7458} {RNA1310_36212} {RNA815_1610.1} | |
88. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 1.825 | - | - | - | 0.859 | - | 0.966 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
89. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 1.824 | - | - | - | 0.856 | - | 0.968 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
90. | MligTC455_20015 | 52 | 1.09 | Mlig455_026589 | Neo: - Age: - |
1.823 | - | - | - | 0.864 | - | 0.959 | Mlig455_026589 {REF} {Length: 611} {RNA1310_66647} {RNA815_33955} | |
91. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
1.821 | 0.840 | - | - | - | - | 0.981 | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
92. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
1.819 | 0.837 | - | - | - | - | 0.982 | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
93. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 1.816 | - | - | - | 0.862 | - | 0.954 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
94. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 1.816 | - | - | - | 0.861 | - | 0.955 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
95. | MligTC455_27938 | 137 | 2.85 | Mlig455_033961 | Neo: - Age: - |
1.815 | - | - | - | 0.849 | - | 0.966 | Mlig455_033961 {REF} {Length: 3296} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_28736.1} {RNA815_45605} | |
96. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
1.815 | - | - | - | 0.853 | - | 0.962 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
97. | MligTC455_45095 | 685 | 14.28 | Mlig455_027545 | Neo: - Age: Down-Up-Up Region-enriched R8: 2.453/0.00108 Regeneration-downregulated BL: -7.982 Regeneration-depleted BL: -7.982 |
1.814 | - | - | - | 0.854 | - | 0.960 | Mlig455_027545 {REF} {Length: 449} {RNA1509_40580} {RNA1310_73550} {RNA815_38029} | |
98. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
1.812 | 0.855 | - | - | - | - | 0.957 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
99. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
1.811 | 0.861 | - | - | - | - | 0.950 | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
100. | MligTC455_16171 | 51 | 1.07 | Mlig455_001659, Mlig455_050105 | Neo: - Age: - |
1.81 | - | - | 0.855 | - | - | 0.955 | Mlig455_001659 {REF} {Length: 762} Mlig455_050105 {REF} {Length: 859} |